Coloplast A/S COLOPLAST B ORD SHS/  DK0060448595  /

London International
10/21/2019  6:17:17 PM Chg. -0.60 Volume Bid10/21/2019 Ask10/21/2019 Market Capitalization Dividend Y. P/E Ratio
791.40DKK -0.08% 67,213
Turnover: 53.46 mill.
772.60Bid Size: 1,000 812.20Ask Size: 1,000 153.78 bill.DKK 2.02% 43.66

Business description

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Coloplast's business includes ostomy care, urology and continence care, and wound and skin care.
 

Management board & Supervisory board

CEO
Kristian Villumsen
Management board
Anders Lonning-Skovgaard, Allan Rasmussen, Paul Marcun
Supervisory board
Lars Rasmussen, Birgitte Nielsen, Carsten Hellmann, Jette Nygaard-Andersen, Jørgen Tang-Jensen, Niels Peter Louis-Hansen, Nikolaj Kyhe Gundersen, Roland Vendelbo Pedersen, Thomas Barfod
 

Company data

Name: Coloplast Group
Address: Holtedam 1-3,DK-3050 Humlebaek
Phone: +45-4911-1111
Fax: -
E-mail: coloplast@colopolast.com
Internet: www.coloplast.com/
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 9/30
Free Float: 64.20%
IPO date: -

Investor relations

Name: Ellen Bjurgert
IR phone: +45-4911-3376
IR Fax: +45-4911-1555
IR e-mail: dkebj@coloplast.com

Company calendar

CW 45 | 11/5/2019 4th Quarter/Annual Report
CW 49 | 12/5/2019 General Shareholder Meeting
CW 50 | 12/10/2019 Dividend Payment
 

Main Shareholders

Freefloat
 
64.20%
Niels Peter Louis-Hansen
 
20.70%
Aage og Johanne Louis-Hanses Fond
 
11.40%
Benedicte Find
 
3.70%